AHCO•benzinga•
AdaptHealth Lowers FY2025 Sales Guidance From $3.22B-$3.36B To $3.18B-$3.32B Vs $3.27B Est; Sees Adjusted EBITDA Of $665M To $705M (Prior $670M To $710M)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga